Jeremy I Pearl
Overview
Explore the profile of Jeremy I Pearl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pearl J, Kean L, Davis M, Wu J
Sci Transl Med
. 2012 Dec;
4(164):164ps25.
PMID: 23241742
Human embryonic stem cells (hESCs), initially thought to be immune privileged cells, are now known to be susceptible to immune recognition. Human induced pluripotent stem cells (iPSCs) have been proposed...
2.
Pearl J, Ma T, Irani A, Huang Z, Robinson W, Smith R, et al.
Biomaterials
. 2011 May;
32(24):5535-42.
PMID: 21592562
The inflammatory response to prosthetic implant-derived wear particles is the primary cause of bone loss and aseptic loosening of implants, but the mechanisms by which macrophages recognize and respond to...
3.
Pearl J, Lee A, Leveson-Gower D, Sun N, Ghosh Z, Lan F, et al.
Cell Stem Cell
. 2011 Mar;
8(3):309-17.
PMID: 21362570
Embryonic stem cells (ESCs) are an attractive source for tissue regeneration and repair therapies because they can be differentiated into virtually any cell type in the adult body. However, for...
4.
Swijnenburg R, Govaert J, Van der Bogt K, Pearl J, Huang M, Stein W, et al.
Circ Cardiovasc Imaging
. 2009 Nov;
3(1):77-85.
PMID: 19920031
Background: Despite ongoing clinical trials, the optimal time for delivery of bone marrow mononuclear cells (BMCs) after myocardial infarction is unclear. We compared the viability and effects of transplanted BMCs...
5.
Swijnenburg R, Schrepfer S, Cao F, Pearl J, Xie X, Connolly A, et al.
Stem Cells Dev
. 2008 May;
17(6):1023-9.
PMID: 18491958
Embryonic stem cell (ESC)-based transplantation is considered a promising novel therapy for a variety of diseases. This is bolstered by the suggested immune-privileged properties of ESCs. In this study, we...